(Q69365594)
Statements
Phase I clinical trial of weekly administration of 4'-demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside) (NSC-141540; VP-16-213) (English)
P J Creaven
S J Newman
O S Selawry
M H Cohen
1 November 1974